DTC hearing has high-powered guest list

Hail, hail the gang's all here...at the House Subcommittee on Oversight and Investigations hearing on direct-to-consumer ads. Next week, Rep. Bart Stupak will preside over testimony from Pfizer, Merck, Schering-Plough, and Johnson & Johnson. Kaiser Permanente, the GAO, and the AMA may be there, too.

The official title of the hearing? "Direct-to-Consumer Advertising: Marketing, Education, or Deception?' Not surprising, considering Stupak's history as an industry critic, but definitely not comfortable for those scheduled to say their piece. If you're interested, the committee will offer a video feed.

- see the Pharmalot item
- get the link to the webcast at the committee's site

Related Articles:
Study: Drug ads drown in online noise
To DTC or not to DTC?
Should FDA's info be in all DTC ads?
FDA to study TV drug ad imagery
Survey: No doubt DTC ads work

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.